Regeneron Pharmaceuticals (REGN.VI) Q4 2024 Earnings

31OctConfirmed
Q1 2024
Q2 2024
Q3 2024
Q4 2024
8.9
9.75
10.6
11.45

Details

Expected EPS
10.7441634268
Actual EPS
11.447002
Surprise EPS
0.7
Surprise Percent
+6.54%

Description

Regeneron Pharmaceuticals (REGN.VI) has reported earnings of 11.447002 per share for Q4 2024.

0 Comments

Share your thoughts